BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 20126984)

  • 1. Mining the cancer genome uncovers therapeutic activity of EphA7 against lymphoma.
    Oricchio E; Wendel HG
    Cell Cycle; 2012 Mar; 11(6):1076-80. PubMed ID: 22356769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesis.
    Herath NI; Spanevello MD; Doecke JD; Smith FM; Pouponnot C; Boyd AW
    Eur J Cancer; 2012 Mar; 48(5):753-62. PubMed ID: 21852108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Fruit Waste to Medical Insight: The Comprehensive Role of Watermelon Rind Extract on Renal Adenocarcinoma Cellular and Transcriptomic Dynamics.
    Reddy CS; Natarajan P; Nimmakayala P; Hankins GR; Reddy UK
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-silico and structure-based assessment to evaluate pathogenicity of missense mutations associated with non-small cell lung cancer identified in the Eph-ephrin class of proteins.
    Chakraborty S; Baruah R; Mishra N; Varma AK
    Genomics Inform; 2023 Sep; 21(3):e30. PubMed ID: 37813626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of EphA7 in different tumors.
    Chen X; Yu D; Zhou H; Zhang X; Hu Y; Zhang R; Gao X; Lin M; Guo T; Zhang K
    Clin Transl Oncol; 2022 Jul; 24(7):1274-1289. PubMed ID: 35112312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the soluble EphA7-interacting protein Nicalin as a regulator of EphA7 expression.
    Wang X; Wang Z
    Mol Cell Biochem; 2021 Jan; 476(1):213-220. PubMed ID: 32914261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7.
    Di W; Weinan X; Xin L; Zhiwei Y; Xinyue G; Jinxue T; Mingqi L
    Cell Death Dis; 2019 Jul; 10(7):514. PubMed ID: 31273190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines.
    Januchowski R; Sterzyńska K; Zawierucha P; Ruciński M; Świerczewska M; Partyka M; Bednarek-Rajewska K; Brązert M; Nowicki M; Zabel M; Klejewski A
    Oncotarget; 2017 Jul; 8(30):49944-49958. PubMed ID: 28611294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7.
    Wu X; Yan L; Liu Y; Xian W; Wang L; Ding X
    PLoS One; 2017; 12(6):e0175553. PubMed ID: 28604772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells.
    Johnson C; Segovia B; Kandpal RP
    Cancer Genomics Proteomics; 2016 09-10; 13(5):359-68. PubMed ID: 27566654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer.
    Shinmura K; Kurabe N; Goto M; Yamada H; Natsume H; Konno H; Sugimura H
    Mol Biol Rep; 2014 Oct; 41(10):6635-44. PubMed ID: 24981932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.
    Giaginis C; Tsoukalas N; Bournakis E; Alexandrou P; Kavantzas N; Patsouris E; Theocharis S
    BMC Clin Pathol; 2014 Feb; 14(1):8. PubMed ID: 24495444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers.
    Wu X; Wang L; Ye Y; Aakre JA; Pu X; Chang GC; Yang PC; Roth JA; Marks RS; Lippman SM; Chang JY; Lu C; Deschamps C; Su WC; Wang WC; Huang MS; Chang DW; Li Y; Pankratz VS; Minna JD; Hong WK; Hildebrandt MA; Hsiung CA; Yang P
    Cancer Res; 2013 Jul; 73(13):4028-38. PubMed ID: 23704207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian ensemble approach with a disease gene network predicts damaging effects of missense variants of human cancers.
    Won HH; Kim JW; Lee D
    Hum Genet; 2013 Jan; 132(1):15-27. PubMed ID: 22907477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EPH-EPHRIN in human gastrointestinal cancers.
    Sugimura H; Wang JD; Mori H; Tsuboi M; Nagura K; Igarashi H; Tao H; Nakamura R; Natsume H; Kahyo T; Shinmura K; Konno H; Hamaya Y; Kanaoka S; Kataoka H; Zhou XJ
    World J Gastrointest Oncol; 2010 Dec; 2(12):421-8. PubMed ID: 21191536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secreted form of EphA7 in lung cancer.
    Tsuboi M; Mori H; Bunai T; Kageyama S; Suzuki M; Okudela K; Takamochi K; Ogawa H; Niwa H; Shinmura K; Sugimura H
    Int J Oncol; 2010 Mar; 36(3):635-40. PubMed ID: 20126984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma.
    Wang J; Li G; Ma H; Bao Y; Wang X; Zhou H; Sheng Z; Sugimura H; Jin J; Zhou X
    Hum Pathol; 2007 Nov; 38(11):1649-56. PubMed ID: 17669470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of EphA7 by hypermethylation in colorectal cancer.
    Wang J; Kataoka H; Suzuki M; Sato N; Nakamura R; Tao H; Maruyama K; Isogaki J; Kanaoka S; Ihara M; Tanaka M; Kanamori M; Nakamura T; Shinmura K; Sugimura H
    Oncogene; 2005 Aug; 24(36):5637-47. PubMed ID: 16007213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of the GATA genes in lung cancer.
    Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
    Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.